AcquisitionOther
VISION SENSING ACQUISITION CORP. acquired Mediforum Co., Ltd The Combined Company Is Expected To Trade On Nasdaq Post-Closing
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
VISION SENSING ACQUISITION CORP. -> Mediforum Co., Ltd The Combined Company Is Expected To Trade On Nasdaq Post-Closing · $250 million
● Mediforum has been principally involved in drug development with two pipeline drugs: PM012 for Alzheimer's Disease (AD); and MF018 for Chemotherapy-Induced Peripheral Neuropathy (CIPN), both currently are in Phase 2b and Phase 2 clinical trials in Korea, res
Open source record (SEC) ↗